What is the Highest Dosage of Wegovy for Weight Loss?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, comes in escalating doses that build over 16 weeks to reduce nausea and maximize tolerability. The highest maintenance dose used in clinical trials was 2.4 mg once weekly, but reaching that level isn't necessary or right for every person seeking weight loss.

Understanding Semaglutide Dose Escalation Protocols

Semaglutide treatment follows a carefully structured titration schedule designed to minimize side effects while allowing your body to adapt. Patients begin at 0.25 mg weekly for four weeks, then increase by 0.25 mg increments every four weeks until reaching their target dose. This gradual approach reduces nausea, appetite changes, and gastrointestinal discomfort that can occur with rapid dose jumps. Most people feel significantly less appetite suppression at lower doses, which some patients prefer for lifestyle flexibility.

The standard titration path moves from 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg over 16 weeks. However, your healthcare provider may pause increases at any level if you're experiencing effective weight loss and good tolerability, or they may extend the timeline between dose changes. The goal isn't to reach the highest dose—it's to find your therapeutic sweet spot where weight loss, appetite control, and side effects all align with your personal goals.

Why 2.4 mg Is the Maximum But Not Always the Best

The 2.4 mg weekly dose emerged from the STEP clinical trials, where it produced the most significant weight loss results in participants with obesity and type 2 diabetes. In these studies, patients on 2.4 mg semaglutide lost an average of 15% of their body weight over 68 weeks compared to 2.6% with placebo. However, higher doses also correlated with higher rates of nausea, vomiting, and other gastrointestinal side effects, meaning more patients discontinued treatment at maximum strength. Effectiveness at lower doses like 1.7 mg was still substantial—approximately 11% average weight loss—without the intensity of side effects.

Your body's individual response to semaglutide depends on factors like your baseline metabolism, gut sensitivity, concurrent medications, and genetic predispositions. Some patients achieve their target weight loss and prefer to stabilize at 1.0 mg or 1.7 mg, while others tolerate and benefit from the full 2.4 mg dose. PlexusDx recognizes this variability through personalized assessment rather than assuming everyone needs maximum dosing.

How Genetic Factors Influence Your Optimal Semaglutide Dose

Your GLP-1 receptor sensitivity, appetite regulation genes, and metabolic pathways all influence how effectively semaglutide works for you at different dose levels. Genetic variants in the GLP1R gene (like rs6923761) affect how strongly your cells respond to semaglutide's signal, while FTO gene variants (rs9939609) influence baseline appetite drive and weight regulation. A person with a variant that enhances GLP1R sensitivity may experience excellent appetite suppression and weight loss at 1.0 mg, while someone with reduced receptor sensitivity might need 2.4 mg for comparable effect. The Precision Peptide Genetic Test offered by PlexusDx maps 14 metabolic pathways and 49 peptide-related genes, revealing which semaglutide dose range aligns with your genetic profile.

Understanding your genetic predispositions removes guesswork from dose selection and can accelerate the process of finding your therapeutic sweet spot. Rather than climbing to 2.4 mg over 16 weeks hoping it's optimal, PlexusDx's genetic insights allow your provider to anticipate your likely dose response and adjust your titration strategy accordingly. This personalized approach means fewer trial-and-error cycles and faster achievement of your weight loss goals.

Semaglutide Dosing and Weight Loss Results at Each Level

Clinical data shows a dose-response curve where weight loss improvements increase with higher semaglutide doses, but the relationship plateaus. At 0.5 mg weekly, average weight loss was approximately 3–4% of body weight; at 1.0 mg, patients averaged 6–7% loss; at 1.7 mg, average loss reached 11%; and at 2.4 mg, the average rose to 15%. However, these are population-level means—individual results vary significantly based on adherence, diet, exercise, and the genetic factors mentioned above. A patient with strong GLP1R sensitivity might achieve 12% weight loss at 1.7 mg, while someone requiring 2.4 mg achieves 14%, a modest additional gain for increased side effect risk.

Side effects also escalate with dose: nausea and vomiting affect roughly 25% of people at 1.0 mg but increase to 40% at 2.4 mg, though most cases are mild to moderate. Constipation occurs more frequently at higher doses, and some patients report appetite suppression so intense at 2.4 mg that they struggle to eat enough to maintain energy. These trade-offs mean that the 'highest' dose isn't the 'best' dose—the best dose is the one you can sustain long-term with acceptable tolerability and meaningful weight loss results. PlexusDx's compounded semaglutide allows flexible dosing without price increases, so you can optimize at your ideal level without financial pressure to climb higher.

Access Semaglutide at Your Optimal Dose with PlexusDx

PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, with a flat monthly price regardless of whether your prescription is 0.25 mg or 2.4 mg. Your dose may need to go up, but your price won't—a crucial difference from other providers who charge incrementally based on dose strength. All medications come from licensed 503A compounding pharmacies verified for purity and potency, and PlexusDx serves all 50 states without requiring insurance or membership fees. HSA and FSA accounts are eligible, making treatment accessible to most budgets.

After your first month of treatment, the optional Precision Peptide Genetic Test ($298) provides actionable insights into your peptide-pathway genes, allowing your PlexusDx provider to refine your dose trajectory based on your unique biology. Whether you're starting semaglutide for the first time or adjusting your current regimen, PlexusDx's personalized approach and transparent pricing remove barriers to finding your therapeutic dose without overpaying or overshooting into unnecessary higher strengths.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the highest dose of semaglutide prescribed for weight loss?

The maximum semaglutide dose used in weight loss studies is 2.4 mg once weekly, which was approved for Wegovy in 2021. However, many patients achieve excellent results at 1.0–1.7 mg and prefer lower doses due to fewer side effects. Your ideal dose depends on your individual response, tolerability, and weight loss goals, not simply on reaching the highest available strength.

Does a higher dose of semaglutide always mean better weight loss results?

No—while clinical data shows that higher doses produce greater average weight loss (2.4 mg averaged 15% loss vs. 1.7 mg at 11%), individual genetics and metabolism make outcomes highly variable. Some patients lose 12–14% at 1.7 mg without the nausea and constipation that plague others at 2.4 mg, making a lower dose objectively 'better' for their situation.

How does PlexusDx pricing work if my dose increases over time?

PlexusDx charges a flat $189 per month for compounded semaglutide injections, regardless of dose strength from 0.25 mg to 2.4 mg. Your dose may need to go up as you titrate, but your monthly price remains the same—eliminating the financial pressure to stay below higher strengths or to jump to a maximum dose prematurely.

What side effects are more common at the highest semaglutide doses?

Nausea, vomiting, and constipation increase in frequency at 2.4 mg compared to lower doses, affecting roughly 40% of patients (vs. 25% at 1.0 mg). Most cases are mild to moderate and improve over time, but some patients discontinue treatment due to intensity of nausea or difficulty maintaining adequate nutrition from appetite suppression.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test identifies your GLP1R sensitivity status and 13 other metabolic pathways, allowing your PlexusDx provider to anticipate whether you'll respond robustly at lower doses or need higher strengths. While genetics don't determine dose perfectly, this $298 after your first treatment month can accelerate your path to your therapeutic sweet spot.

Related Reading

• Wegovy For Weight Loss 2
• Glp 1 Dosage For Weight Loss
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.